FY22 Results Presentation

2 March 2023

Disclaimer

These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the "Company"), including with respect to the progress, timing and completion of the Company's development, the Company's ability to treat, attract, and retain patients and customers, its ability to engage consultants and GPs and to operate its business and increase referrals, the integration of prior acquisitions, the Company's estimates for future performance and its estimates regarding anticipated operating results, future revenues, capital requirements, shareholder structure and financing. In addition, even if the Company's actual results or development are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of the Company's results or developments in the future. In some cases, you can identify forward-looking statements by words such as "could,"

"should," "may," "expects," "aims," "targets," "anticipates," "believes," "intends," "estimates," or similar words. These forward-looking statements are based largely on the Company's current

expectations as of the date of this presentation and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievement expressed or implied by these forward-looking statements. In particular, the Company's expectations could be affected by, among other things, uncertainties involved in the integration of acquisitions or new developments, changes in legislation or the regulatory regime governing healthcare in the UK, poor performance by consultants who practice at our facilities, unexpected regulatory actions or suspensions, competition in general, the impact of global economic changes, and the Company's ability to obtain or maintain accreditation or approval for its facilities or service lines. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements made during this presentation will in fact be realised and no representation or warranty is given as to the completeness or accuracy of the forward-looking statements contained in these materials.

The Company is providing the information in these materials as of this date, and we disclaim any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

2

Zoom webinar rules of engagement

All attendee lines are muted

The chat function is disabled

Please submit your name and organisation using the Q&A function

Angus will moderate the session and unmute your line for you to ask your question

Any problems please email Laura.Young@spirehealthcare.com

3

Agenda

FY22 Overview

Justin Ash, Chief Executive Officer

FY22 Financial review

Jitesh Sodha, Chief Financial Officer

Strategic developments

Justin Ash, Chief Executive Officer

Expanding our proposition

Peter Corfield, Chief Commercial Officer

Outlook for FY23

Justin Ash, Chief Executive Officer

Q&A

4

FY22 Overview

Justin Ash, Chief Executive Officer

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Spire Healthcare Group plc published this content on 02 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 March 2023 09:54:57 UTC.